4.8 Review

Regulation of gut microbiota-bile acids axis by probiotics in inflammatory bowel disease

Related references

Note: Only part of the references are listed.
Review Microbiology

Bile acid-gut microbiota crosstalk in irritable bowel syndrome

Yu Gu et al.

Summary: This article discusses the complex relationship between bile acids and gut microbiota in the pathogenesis of irritable bowel syndrome (IBS), as well as the possible molecular mechanisms and biomarkers. In addition, it evaluates therapeutic strategies for IBS that regulate the bile acid-gut microbiota axis. These studies provide new insights into the treatment of IBS.

CRITICAL REVIEWS IN MICROBIOLOGY (2023)

Article Medicine, Research & Experimental

Pediococcus pentosaceus CECT 8330 protects DSS-induced colitis and regulates the intestinal microbiota and immune responses in mice

Fang Dong et al.

Summary: The study demonstrated that P. pentosaceus CECT 8330 treatment protected against DSS-induced colitis in mice by reducing weight loss, disease activity index, histological damage, and colon length shortening. It also modulated the immunological profiles and gut microbiota composition and function, suggesting its potential as a promising probiotic for alleviating intestinal inflammation.

JOURNAL OF TRANSLATIONAL MEDICINE (2022)

Article Biochemistry & Molecular Biology

Lactiplantibacillus plantarum DMDL 9010 alleviates dextran sodium sulfate (DSS)-induced colitis and behavioral disorders by facilitating microbiota-gut-brain axis balance

Yan-yan Huang et al.

Summary: Intake of LP9010 probiotic supplement can ameliorate depressive-like behavior induced by DSS by reducing inflammation, repairing intestinal barrier damage, and lightening depressive behavior. Additionally, LP9010 supplementation inhibits neuroinflammation by reorganizing the gut microbiota, increasing neurotransmitter levels, and boosting short-chain fatty acid levels.

FOOD & FUNCTION (2022)

Article Plant Sciences

Beneficial Role of Fruits, Their Juices, and Freeze-Dried Powders on Inflammatory Bowel Disease and Related Dysbiosis

Maria Rosaria Perri et al.

Summary: Inflammatory bowel disease (IBD) is a chronic condition affecting the gastrointestinal tract. Diet plays an important role in both its cause and treatment. Fruit consumption has beneficial effects on the gut microbiota.

PLANTS-BASEL (2022)

Article Nutrition & Dietetics

Lactobacillus coryniformis MXJ32 administration ameliorates azoxymethane/dextran sulfate sodium-induced colitis-associated colorectal cancer via reshaping intestinal microenvironment and alleviating inflammatory response

Tao Wang et al.

Summary: The study showed that Lactobacillus coryniformis MXJ32 effectively reduced tumor growth in the colitis-associated colorectal cancer mouse model by improving intestinal barrier function, alleviating inflammation, and balancing gut microbiota composition.

EUROPEAN JOURNAL OF NUTRITION (2022)

Review Microbiology

Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis

Jie Cai et al.

Summary: Inflammatory bowel disease (IBD) and colorectal cancer (CRC) are diverse intestinal diseases threatening an increasing number of individuals as their lifestyles become westernized. Recent research has found that gut microbiota-derived metabolites play a crucial role in maintaining intestinal homeostasis and modulating the progression of intestinal diseases.

CELL HOST & MICROBE (2022)

Article Multidisciplinary Sciences

Human gut bacteria produce TH17-modulating bile acid metabolites

Donggi Paik et al.

Summary: This study identifies bile acids produced by gut bacteria that inhibit the differentiation of T(H)17 cells, a key immune cell type involved in inflammatory disorders such as inflammatory bowel disease. The levels of these bile acids are reduced in patients with inflammatory bowel disease and are inversely correlated with the expression of T(H)17-cell-associated genes.

NATURE (2022)

Article Chemistry, Multidisciplinary

Hierarchy-Assembled Dual Probiotics System Ameliorates Cholestatic Drug-Induced Liver Injury via Gut-Liver Axis Modulation

Qi-Wen Chen et al.

Summary: Cholestatic drug-induced liver injury (DILI), a severe clinical syndrome, can be effectively prevented by living materials consisting of dual probiotics that modulate the gut-liver axis. The constructed materials release probiotic Lactobacillus rhamnosus GG in the intestines, which inhibits hepatic bile acid synthesis and promotes bile acid excretion. Additionally, the materials absorb excessive bile acids and decrease their total amount in the enterohepatic circulation.

ADVANCED SCIENCE (2022)

Review Immunology

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics

Quan Lu et al.

Summary: This review explains the interactions among symbiotic flora, intestinal epithelial cells, and the immune system, clarifies the operating mechanism of the intestinal immune system, and highlights the immunological pathogenesis of IBD with a focus on the development of immunotherapy for IBD.

JOURNAL OF INFLAMMATION RESEARCH (2022)

Article Biochemistry & Molecular Biology

Intestinal transgene delivery with native E. coli chassis allows persistent physiological changes

Baylee J. Russell et al.

Summary: This study demonstrates the potential of using native bacteria as chassis for transgene delivery to manipulate the gut microbiome and reverse pathology in conventionally raised hosts.
Article Biotechnology & Applied Microbiology

Physiological Characteristics of Lactobacillus casei Strains and Their Alleviation Effects against Inflammatory Bowel Disease

Yang Liu et al.

Summary: This study successfully identified Lactobacillus casei strain M2S01 as effective in alleviating inflammatory bowel disease (IBD), with its effects attributed to inhibiting the NF-kappa B pathway and restoring a healthy gut microbiome composition. A good gastrointestinal tolerance ability may be one of the prerequisites for the IBD-alleviating effects of L. casei.

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY (2021)

Article Agriculture, Multidisciplinary

An appraisal of the gut health modulatory effects of a calf faecal-origin probioticLactobacillus salivariusCPN60usingWistarrats with dextran sulfate sodium-induced colitis

Mokshata Gupta et al.

Summary: The dietary supplementation of calf-origin probiotic had positive effects on both healthy rats and rats with experimental colitis, including improving nutrient digestibility, increasing levels of short-chain fatty acids, reducing ammonia levels, and boosting beneficial bacteria counts in the colon.

JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE (2021)

Review Gastroenterology & Hepatology

Bile Acid Signaling in Inflammatory Bowel Diseases

Stefano Fiorucci et al.

Summary: Bile acids generated at the host liver and through microbial metabolism play a crucial role in mediating communication between the intestinal microbiota and host immune system. The expression and function of bile acid-activated receptors are dependent on the structure of the intestinal microbiota, with implications for maintaining a tolerogenic phenotype in the intestine.

DIGESTIVE DISEASES AND SCIENCES (2021)

Article Agriculture, Multidisciplinary

Probiotic Bacillus cereus Alleviates Dextran Sulfate Sodium-Induced Colitis in Mice through Improvement of the Intestinal Barrier Function, Anti-Inflammation, and Gut Microbiota Modulation

Kangliang Sheng et al.

Summary: The study demonstrated that Bacillus cereus can alleviate colitis symptoms in mice by modulating macrophages, suppressing inflammation, and rebalancing gut microbiota.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Article Agriculture, Multidisciplinary

Bifidobacterium longum Ameliorates Dextran Sulfate Sodium-Induced Colitis by Producing Conjugated Linoleic Acid, Protecting Intestinal Mechanical Barrier, Restoring Unbalanced Gut Microbiota, and Regulating the Toll-Like Receptor-4/Nuclear Factor-κB Signaling Pathway

Yang Chen et al.

Summary: Bifidobacterium longum CCFM681 alleviated colitis by protecting the intestinal mechanical barrier, modulating gut microbiota, inhibiting the TLR4/NF-kappa B pathway, and increasing colonic CLA concentrations. The effectiveness of relieving colitis showed a significantly positive correlation with CLA concentrations.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Article Microbiology

Prevention and Alleviation of Dextran Sulfate Sodium Salt-Induced Inflammatory Bowel Disease in Mice With Bacillus subtilis-Fermented Milk via Inhibition of the Inflammatory Responses and Regulation of the Intestinal Flora

Xuan Zhang et al.

Summary: The therapeutic effect of B. subtilis-fermented milk on DSS-induced IBD in mice was evaluated in this study. Results showed a decrease in disease activity index, attenuation of intestinal mucosa injury, reduction of inflammatory response, induction of intestinal stem cell proliferation, and promotion of mucosal barrier reconstruction after oral administration of B. subtilis. Additionally, B. subtilis could rebalance the gut microbiota, increasing the abundance of beneficial bacteria while decreasing harmful bacteria.

FRONTIERS IN MICROBIOLOGY (2021)

Article Agriculture, Multidisciplinary

Bifidobacterium pseudocatenulatum Ameliorates DSS-Induced Colitis by Maintaining Intestinal Mechanical Barrier, Blocking Proinflammatory Cytokines, Inhibiting TLR4/NF-κB Signaling, and Altering Gut Microbiota

Yang Chen et al.

Summary: This study found that supplementation with B. pseudocatenulatum strains MY40C and CCFM680 alleviated DSS-induced colitis by protecting the intestinal mechanical barrier, modulating gut microbiota, blocking proinflammatory cytokines, and inhibiting the TLR4/NF-kappa B pathway.

JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2021)

Article Biology

Potential role of Lactobacillus plantarum in colitis induced by dextran sulfate sodium through altering gut microbiota and host metabolism in murine model

Sujuan Ding et al.

Summary: The study demonstrates that Lactobacillus plantarum can alleviate colitis induced by dextran sulfate sodium, with effects on the colonic microbial community and serum metabolites. This research may offer a potential therapeutic strategy for colitis.

SCIENCE CHINA-LIFE SCIENCES (2021)

Article Gastroenterology & Hepatology

Gut Dysbiosis and Abnormal Bile Acid Metabolism in Colitis-Associated Cancer

Li Liu et al.

Summary: The study revealed that gut dysbiosis may lead to abnormal bile acid metabolism and promote the development of CAC in a mouse model. This was characterized by reduced richness and biodiversity of gut microbiota, increased abundance of pathogens, and significantly decreased key bacteria involved in bile acid transformation.

GASTROENTEROLOGY RESEARCH AND PRACTICE (2021)

Article Immunology

Effect of Extracellular Vesicles Derived From Lactobacillus plantarum Q7 on Gut Microbiota and Ulcerative Colitis in Mice

Haining Hao et al.

Summary: Extracellular vesicles (EVs) derived from probiotics like Lactobacillus plantarum Q7 are capable of alleviating DSS-induced colitis symptoms by regulating gut microbiota and reducing proinflammatory cytokine levels. Additionally, Q7-EVs have been shown to improve gut microbiota dysregulation and increase the abundance of anti-inflammatory bacteria, suggesting their potential for alleviating ulcerative colitis.

FRONTIERS IN IMMUNOLOGY (2021)

Article Immunology

Lactic Acid-Producing Probiotic Saccharomyces cerevisiae Attenuates Ulcerative Colitis via Suppressing Macrophage Pyroptosis and Modulating Gut Microbiota

Siyuan Sun et al.

Summary: This study demonstrates that engineered S. cerevisiae can alleviate DSS-induced colitis in mice by suppressing macrophage pyroptosis and modulating the intestinal microbiota, providing an effective and safe treatment strategy for ulcerative colitis.

FRONTIERS IN IMMUNOLOGY (2021)

Article Nutrition & Dietetics

Inhibitory Effects of Breast Milk-Derived Lactobacillus rhamnosus Probio-M9 on Colitis-Associated Carcinogenesis by Restoration of the Gut Microbiota in a Mouse Model

Haiyan Xu et al.

Summary: The study found that the probiotic Lactobacillus rhamnosus M9 (Probio-M9) can suppress tumor formation in the large intestine by regulating the intestinal environment and ameliorating inflammation.

NUTRIENTS (2021)

Article Biochemistry & Molecular Biology

Metabolomics-Guided Hypothesis Generation for Mechanisms of Intestinal Protection by Live Biotherapeutic Products

Jiayu Ye et al.

Summary: This study investigated the effects of two bioengineered LBPs on colon-derived metabolites in colitic mice, demonstrating their anti-inflammatory properties and tissue restoration capabilities. The modified LBPs showed enhanced colonization and persistence in the inflamed intestine, resulting in decreased inflammatory prostaglandins, stress hormones, and bile acid accumulation, while increasing serotonin and antioxidant production.

BIOMOLECULES (2021)

Article Nutrition & Dietetics

Lactobacillus rhamnosus GG Derived Extracellular Vesicles Modulate Gut Microbiota and Attenuate Inflammatory in DSS-Induced Colitis Mice

Lingjun Tong et al.

Summary: Probiotic LGG-EVs show potential in attenuating colitis by inhibiting the TLR4-NF-kappa B-NLRP3 signaling pathway, reducing the release of pro-inflammatory cytokines, and reshaping gut microbiota. These findings suggest a promising therapeutic approach for colitis using oral gavage of LGG-EVs.

NUTRIENTS (2021)

Review Nutrition & Dietetics

Bile Acid-Gut Microbiota Axis in Inflammatory Bowel Disease: From Bench to Bedside

Min Yang et al.

Summary: Inflammatory bowel disease (IBD) is a chronic, relapsing inflammatory disorder of the gastrointestinal tract, associated with dysbiosis of gut microbiota and bile acids, leading to impaired gut barrier and immune function. Restoring gut microbiota and bile acids can alleviate symptoms of IBD.

NUTRIENTS (2021)

Review Cell Biology

Bile Acids Activated Receptors in Inflammatory Bowel Disease

Michele Biagioli et al.

Summary: Bile acids have evolved from being solely involved in nutrient absorption to acting as signaling molecules that activate various immune cells, mediating chemical communication between the intestinal microbiota and the host. Changes in intestinal microbiota can lead to dysbiosis, altering the composition of the bile acid pool and promoting immune system activation and chronic inflammation.

CELLS (2021)

Article Biotechnology & Applied Microbiology

Improved functionality of Ligilactobacillus salivarius Li01 in alleviating colonic inflammation by layer-by-layer microencapsulation

Mingfei Yao et al.

Summary: In this study, a delivery system was designed through layer-by-layer encapsulation to enhance the effectiveness of Li01 in regulating gut microbiota and relieving inflammatory bowel disease. The improved functionality of Li01 by LbL encapsulation increases its potential for clinical applications in IBD treatment.

NPJ BIOFILMS AND MICROBIOMES (2021)

Article Nutrition & Dietetics

Lactobacillus casei protects dextran sodium sulfate- or rapamycin-induced colonic inflammation in the mouse

Yong Zhang et al.

EUROPEAN JOURNAL OF NUTRITION (2020)

Article Biotechnology & Applied Microbiology

Combination of probiotics with different functions alleviate DSS-induced colitis by regulating intestinal microbiota, IL-10, and barrier function

Yanbo Wang et al.

APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2020)

Article Microbiology

Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation

Sidhartha R. Sinha et al.

CELL HOST & MICROBE (2020)

Review Gastroenterology & Hepatology

Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review

Rapat Pittayanon et al.

GASTROENTEROLOGY (2020)

Article Multidisciplinary Sciences

Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells

Clarissa Campbell et al.

NATURE (2020)

Review Microbiology

Criteria to Qualify Microorganisms as Probiotic in Foods and Dietary Supplements

Sylvie Binda et al.

FRONTIERS IN MICROBIOLOGY (2020)

Review Cell Biology

ILC3 function as a double-edged sword in inflammatory bowel diseases

Boning Zeng et al.

CELL DEATH & DISEASE (2019)

Article Gastroenterology & Hepatology

Effects of pentasa-combined probiotics on the microflora structure and prognosis of patients with inflammatory bowel disease

Hua Fan et al.

TURKISH JOURNAL OF GASTROENTEROLOGY (2019)

Article Multidisciplinary Sciences

Bile acid metabolites control TH17 and Treg cell differentiation

Saiyu Hang et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

Microbial impact on cholesterol and bile acid metabolism: current status and future prospects

Aicha Kriaa et al.

JOURNAL OF LIPID RESEARCH (2019)

Article Gastroenterology & Hepatology

GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis

Michele Biagioli et al.

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2019)

Review Gastroenterology & Hepatology

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Wei Jia et al.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Efficacy of Bifidobacterium breve Fermented Milk in Maintaining Remission of Ulcerative Colitis

Katsuyoshi Matsuoka et al.

DIGESTIVE DISEASES AND SCIENCES (2018)

Article Gastroenterology & Hepatology

Comparison of the microbial community structure between inflamed and non-inflamed sites in patients with ulcerative colitis

Atsushi Hirano et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)

Letter Gastroenterology & Hepatology

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis: a role for bifidobacteria and lactobacilli?

Borja Sanchez

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Microbiota modification by probiotic supplementation reduces colitis associated colon cancer in mice

Maria Carolina S. Mendes et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Article Gastroenterology & Hepatology

VSL#3 can prevent ulcerative colitis-associated carcinogenesis in mice

Chun-Sai-Er Wang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2018)

Review Immunology

Bile Acids Activated Receptors Regulate innate immunity

Stefano Fiorucci et al.

FRONTIERS IN IMMUNOLOGY (2018)

Review Biochemistry & Molecular Biology

Interactions between gut bacteria and bile in health and disease

Sarah L. Long et al.

MOLECULAR ASPECTS OF MEDICINE (2017)

Article Immunology

Probiotic strain Lactobacillus casei BL23 Prevents colitis-associated colorectal cancer

Elsa Jacouton et al.

FRONTIERS IN IMMUNOLOGY (2017)

Article Microbiology

Next-generation probiotics: the spectrum from probiotics to live biotherapeutics

Paul W. O'Toole et al.

NATURE MICROBIOLOGY (2017)

Article Gastroenterology & Hepatology

Modulation of the microbiota-gut-brain axis by probiotics in a murine model of inflammatory bowel disease

Jacob R. Emge et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2016)

Article Biochemistry & Molecular Biology

Splenic dendritic cell involvement in FXR-mediated amelioration of DSS colitis

Vittoria Massafra et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2016)

Article Engineering, Biomedical

The long-term effects of probiotics in the therapy of ulcerative colitis: A clinical study

Vincenzo Davide Palumbo et al.

BIOMEDICAL PAPERS-OLOMOUC (2016)

Review Food Science & Technology

Bile Acid Modifications at the Microbe-Host Interface: Potential for Nutraceutical and Pharmaceutical Interventions in Host Health

Susan A. Joyce et al.

ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 7 (2016)

Article Biochemical Research Methods

Crystal structure of bile salt hydrolase from Lactobacillus salivarius

Fuzhou Xu et al.

ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS (2016)

Review Gastroenterology & Hepatology

Consequences of bile salt biotransformations by intestinal bacteria

Jason M. Ridlon et al.

GUT MICROBES (2016)

Article Biochemistry & Molecular Biology

A biosynthetic pathway for a prominent class of microbiota-derived bile acids

A. Sloan Devlin et al.

NATURE CHEMICAL BIOLOGY (2015)

Article Gastroenterology & Hepatology

Effectiveness of probiotic therapy for the prevention of relapse in patients with inactive ulcerative colitis

Yasushi Yoshimatsu et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2015)

Article Microbiology

The Treatment-Naive Microbiome in New-Onset Crohn's Disease

Dirk Gevers et al.

CELL HOST & MICROBE (2014)

Review Gastroenterology & Hepatology

A tale of two diseases: The history of inflammatory bowel disease

Daniel J. Mulder et al.

JOURNAL OF CROHNS & COLITIS (2014)

Article Multidisciplinary Sciences

Regulation of host weight gain and lipid metabolism by bacterial bile acid modification in the gut

Susan A. Joyce et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Pharmacology & Pharmacy

Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression

Joerg Jahnel et al.

DRUG METABOLISM AND DISPOSITION (2014)

Review Gastroenterology & Hepatology

A tale of two diseases: The history of inflammatory bowel disease

Daniel J. Mulder et al.

JOURNAL OF CROHNS & COLITIS (2014)

Article Microbiology

Metabolism of Cholesterol and Bile Acids by the Gut Microbiota

Philippe Gerard

PATHOGENS (2014)

Article Gastroenterology & Hepatology

Saccharomyces boulardii Does Not Prevent Relapse of Crohn's Disease

Arnaud Bourreille et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Physiology

Bile Acid Metabolism and Signaling

John Y. L. Chiang

COMPREHENSIVE PHYSIOLOGY (2013)

Article Gastroenterology & Hepatology

Effect of Probiotics on Serum Bile Acids in Patients with Ulcerative Colitis

Shinji Sato et al.

HEPATO-GASTROENTEROLOGY (2012)

Article Biotechnology & Applied Microbiology

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

Xochitl C. Morgan et al.

GENOME BIOLOGY (2012)

Article Integrative & Complementary Medicine

Clinical trial: probiotic treatment of acute distal ulcerative colitis with rectally administered Escherichia coli Nissle 1917 (EcN)

Harald Matthes et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2010)

Article Gastroenterology & Hepatology

Effect of a Probiotic Preparation (VSL# 3) on Induction and Maintenance of Remission in Children With Ulcerative Colitis

Erasmo Miele et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

The Probiotic Preparation, VSL#3 Induces Remission in Patients With Mild-to-Moderately Active Ulcerative Colitis

Ajit Sood et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)

Article Immunology

The Bile Acid Receptor FXR Is a Modulator of Intestinal Innate Immunity

Piero Vavassori et al.

JOURNAL OF IMMUNOLOGY (2009)

Article Multidisciplinary Sciences

Functional and comparative metagenomic analysis of bile salt hydrolase activity in the human gut microbiome

Brian V. Jones et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

Daniel N. Frank et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)

Article Gastroenterology & Hepatology

Human cecal bile acids: concentration and spectrum

James P. Hamilton et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2007)

Article Gastroenterology & Hepatology

Clinical effectiveness of probiotics therapy (BIO-THREE) in patients with ulcerative colitis refractory to conventional therapy

Yukiko Tsuda et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2007)

Review Biotechnology & Applied Microbiology

Bile salt hydrolase activity in probiotics

M Begley et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2006)

Review Biochemistry & Molecular Biology

Bile salt biotransformations by human intestinal bacteria

JM Ridlon et al.

JOURNAL OF LIPID RESEARCH (2006)

Article Gastroenterology & Hepatology

VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis

R Bibiloni et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)

Article Multidisciplinary Sciences

Diversity of the human intestinal microbial flora

PB Eckburg et al.

SCIENCE (2005)